Trial intelligence / Profile preview

Growth Hormone in Ischemic Heart Failure

NCT04420481Phase 3Completed

Sponsor
University of Gothenburg
Start
Apr 2004
Primary completion
Feb 2012
Modality
Hormone, rProtein (Recombinant Protein), Biologic
01

Overview

A Phase 3 trial of somatropin in Ischemic Heart Failure (IHF), sponsored by University of Gothenburg. Started Apr 2004; status: completed.

02

Drugs

somatropin
03

Conditions

Ischemic Heart Failure (IHF)

Beyond the preview

Go deeper on NCT04420481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04420481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call